AMENDED AND RESTATED RESEARCH COLLABORATION AND LICENCE AGREEMENT RELATING TO GENE EDITING AND HLA-ENGINEERING TECHNOLOGYResearch Collaboration and License Agreement • February 27th, 2020 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • England
Contract Type FiledFebruary 27th, 2020 Company Industry JurisdictionThis AMENDED AND RESTATED RESEARCH COLLABORATION AND LICENCE AGREEMENT (the “Agreement”) is made as of the 25th day of November 2015 (the “Effective Date”) and amended as of January 13, 2020 (the “Amendment Date”) by and between:
AGREEMENT BETWEEN: ADAPTIMMUNE LIMITED (1) and UNIVERSAL CELLS, INC. (2)Research Collaboration and License Agreement • March 17th, 2016 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • England
Contract Type FiledMarch 17th, 2016 Company Industry JurisdictionThis RESEARCH COLLABORATION AND LICENCE AGREEMENT (the “Agreement”) is made as of the 25th day of November 2015 (the “Effective Date”) by and between: